Document is current

Article History

Received: 30 November 2025

Accepted: 11 March 2026

First Online: 2 May 2026

Declarations

:

: Laura Weydandt has received honoraria and travel support from AstraZeneca, Eisai, Lilly, Menarini Stemline, Novartis, Pfizer and a part-time job at the West German Study Group. Saida Agabejli has received honoraria and travel support from: MSD, Novartis, Pfizer, Lilly, Gilead, Astra Zeneca, Stemline, Pierre Fabre, Abbvie. Saida Agabejli participates at advisory boards from GSK, Novartis, Astra Zeneca, Stemline, Daiichi Sankyo. Pauline Wimberger has received research funding for institution from Amgen, abbvie, AstraZeneca, MSD, GlaxoSmithKline, Novartis, Pfizer, Roche Pharma, Clovis, Lilly. Honoraria from Amgen, abbvie, AstraZeneca, MSD, GlaxoSmithKline, Novartis, Pfizer, Roche Pharma, Clovis, TEVA, Eisai, Lilly, Gilead, Daichii Sankyo. Pauline Wimberger participates at advisory boards from Amgen, abbvie, AstraZeneca, MSD, GlaxoSmithKline, Novartis, Pfizer, Roche Pharma, Clovis, TEVA, Eisai, Lilly, Gilead and Daichii Sankyo. Bahriye Aktas has received honoraria from Amgen, AstraZeneca, Daiichi-Sankyo, Eisai, Genomic Health, Gilead, Lilly, MSD, Medtronic, Novartis, Onkowissen, Pfizer, Roche, Stemline, Tesaro. Theresa Link has received honoraria and travel support from Amgen, Roche, MSD, Novartis, Pfizer, Lilly, GSK, Gilead, Astra Zeneca, Daiichi Sankyo, Stemline, Seagen. Theresa Link participates at advisory boards from MSD, Roche, Pfizer, Lilly, Myriad, Esai, GSK, Gilead, Daiichi Sankyo, Roche, Astra Zeneca. Massimiliano Lia has no competing interests.

: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the ethics committee of the medical faculty of the university of Leipzig (protocol code: 416/23-ek, date of approval: 17 January 2024 and Dresden (protocol code: EK-34012024, date of approval: 21 February 2024).